cagrilintide phase 3 CagriSema in Adults With or Without Diabetes – REDEFINE 1 & 2 • 💊 2.4 mg + Semaglutide 2.4 mg once weekly • 📉 –20.4% weight loss (non-diabetic) & –13.7% (T2D) Cagrilintide–semaglutide (CagriSema) as an add-on

Description

Gut lining repair: Patients with SIBO residual symptoms, chronic GI distress, leaky gut, or post-antibiotic damage to the intestinal mucosa

The standard starting dose is 0.5mg once weekly, with increases every four weeks following a structured schedule

FDA-approved drugs have completed Phase I through Phase III clinical trials, received formal approval for specific indications, and carry standardized dosing and labeling

The Opt-Powder device by Optinose is a breath-actuated bi-directional delivery device that targets liquid or nasal powder formulations to the nasal cavity, including the olfactory region